lilly glp 1 drug FDA approves new weight-loss pill, Foundayo Orforglipron: Eli Lilly's New Oral

So I think theres a concern here that, if you start prescribing this, for addiction that there will be a point in which when theyre no longer on the a, the medications that their cravings for cocaine or alcohol or heroin, you name it will return and thats a concern because if you have stopped using a substance as powerful as heroin for a period of time and then you end up going back to it, then your tolerance is much reduced and your risk of overdose is much, much higher

doi: 10.3389/fmicb.2023.1088187 74 LiangLSuXGuanYWuBZhangXNianX

Kerr JS, Adriaanse BA, Greig NH, et al

Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA

Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial